Vimarsana
Biggest News Aggregation in the World

Page 46 - Thomas Triomphe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Triomphe Today - Breaking & Trending Today

Sanofi, GlaxoSmithKline report positive trial results of COVID-19 vaccine - Vimarsana News

Sanofi, GlaxoSmithKline report positive trial results of COVID-19 vaccine

Persons who were previously infected by the coronavirus produced high levels after a single injection, giving the companies hope that their vaccine could serve as an effective booster. The drugmakers plan to enroll more than 35,000 adults in multiple countries to test the shots against the original strain and the aggressive South Africa variant. Several COVID-19 vaccines are circulating now, though scientists say it is good to employ multiple options to bolster supply and have a range of vaccine platforms capable of fighting the wily virus. Sanofi’s recombinant technology inserts genetic in...

GSK and Sanofi hope to have Covid vaccine ready this year | Darlington and Stockton Times - Vimarsana News

GSK and Sanofi hope to have Covid vaccine ready this year | Darlington and Stockton Times

Glaxo hopes to have its Covid-19 vaccine ready by end of year as trials progress DRUGS manufacturer Glaxo is ready to move onto the next stage of its Covid-19 vaccine trial as it looks to have it in use by the end of the year. GlaxoSmithKline, which has a site in Barnard Castle, and Sanofi’s Covid-19 vaccine saw strong results from its phase 2 trial and will now move on to a larger phase 3 trial as the drugs firms try to catch up with the competition. Interim results from the study show a 95 per cent to 100 per cent seroconversion following a second injection in patients from ages 1...

France's Sanofi, Britain's GSK report good trial results for new Covid vaccine - Vimarsana News

France's Sanofi, Britain's GSK report good trial results for new Covid vaccine

France's Sanofi, Britain's GSK report good trial results for new Covid vaccine Issued on: 17/05/2021 - 12:24 Sanofi global head Thomas Triomphe said the Covid vaccine developed with GSK could "play a role in addressing this ongoing global public health crisis". JOEL SAGET AFP/File 3 min French pharmaceuticals giant Sanofi and Britain's GSK on Monday reported positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hopes that it could be ready in months. Advertising Read mor...

Source: rfi.fr
Phase two trials find UK-made GSK vaccine produces strong immune response - Vimarsana News

Phase two trials find UK-made GSK vaccine produces strong immune response

Britain could have another Covid vaccine in its arsenal by the end of the year after GlaxoSmithKline and Sanofi's jab produced promising results today. The British-French vaccine was found to trigger a 'strong' immune response against the virus, according to phase two trial results. All 700 volunteers given the experimental two-dose jab had high levels of Covid-fighting antibodies in their blood.  There were no safety concerns among participants, who were 18 to 95 years old.  The shot will now move to Phase 3 trials which will involve more than 35,000 adults across several countries. They...

Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback - Vimarsana News

Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback

Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback A COVID-19 vaccine developed by Sanofi and GlaxoSmithKline showed a robust immune response in early-stage clinical trial results, enabling them to move to a late-stage study, the companies announced on Monday. Social Sharing CBC News · Posted: May 17, 2021 11:34 AM ET | Last Updated: May 17 The federal government recently announced financial support to help French company Sanofi bolster vaccine production in Toronto. (Oliver Walters/CBC) A COVID-19 vaccine developed by Sanofi and GlaxoSmithKline ...

Source: cbc.ca